Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.91% |
| 2 | Technology | 7.43% |
| 3 | Financials | 6.52% |
| 4 | Consumer Discretionary | 5.69% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Thomson Reuters
TRI
$45.7B
| $14.7M | 0.03% |
205,439
-590,289
| -74% | -$46M |
|
602
Sarepta Therapeutics
SRPT
$1.98B
| $14.6M | 0.03% |
149,744
-7,883
| -5% | -$901K |
|
603
Workiva
WK
$4.07B
| $14.6M | 0.03% |
451,887
+166,972
| +59% | +$6.94M |
|
604
PUT
Thermo Fisher Scientific
TMO
$233B
| $14.6M | 0.03% |
51,400
+33,500
| +187% | +$10.6M |
|
605
AtriCure
ATRC
$2.49B
| $14.6M | 0.03% |
433,193
-47,745
| -10% | -$1.72M |
|
606
CALL
State Street SPDR S&P Retail ETF
XRT
$491M
| $14.5M | 0.03% |
487,200
+121,900
| +33% | +$4.93M |
|
|
HOLX
607
DELISTED
Hologic
HOLX
| $14.5M | 0.03% |
413,257
-685,975
| -62% | -$32.7M |
|
608
Gaotu Techedu
GOTU
$401M
| $14.5M | 0.03% |
342,190
+278,838
| +440% | +$10.3M |
|
609
Iron Mountain
IRM
$36.3B
| $14.5M | 0.03% |
+607,484
| New | +$18.4M |
|
610
Philips
PHG
$26.8B
| $14.5M | 0.03% |
452,864
+117,548
| +35% | +$4.16M |
|
|
KLR.WS
611
CALL
DELISTED
Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share
KLR.WS
| $14.4M | 0.03% |
1,975,200
+1,675,200
| +558% | +$1.75M |
|
612
Sysco
SYY
$40.2B
| $14.4M | 0.03% |
315,665
+310,132
| +5,605% | +$21.5M |
|
|
CCXI
613
DELISTED
ChemoCentryx, Inc.
CCXI
| $14.3M | 0.03% |
355,231
-19,753
| -5% | -$839K |
|
614
Insperity
NSP
$2.02B
| $14.2M | 0.03% |
381,980
+365,330
| +2,194% | +$25.9M |
|
615
Dolby
DLB
$6.11B
| $14.2M | 0.03% |
262,299
+208,143
| +384% | +$13.6M |
|
|
AXNX
616
DELISTED
Axonics, Inc. Common Stock
AXNX
| $14.2M | 0.03% |
558,696
-1,376,442
| -71% | -$40.9M |
|
|
NBL
617
DELISTED
Noble Energy, Inc.
NBL
| $14.2M | 0.03% |
2,348,354
+2,300,088
| +4,765% | +$36.9M |
|
618
DraftKings
DKNG
$13B
| $14.1M | 0.03% |
1,146,118
+1,031,118
| +897% | +$14.8M |
|
619
CALL
JD.com
JD
$39.7B
| $14.1M | 0.03% |
348,800
+102,100
| +41% | +$4.08M |
|
|
SCVX.U
620
DELISTED
SCVX Corp. Units, each consisting of one Class A ordinary share, $0.0001 par value per share, and on
SCVX.U
| $14.1M | 0.03% |
+1,414,300
| New | +$14.4M |
|
|
HPP
621
Hudson Pacific Properties
HPP
$787M
| $14.1M | 0.03% |
79,163
+4,284
| +6% | +$979K |
|
|
RP
622
DELISTED
RealPage, Inc.
RP
| $14M | 0.03% |
265,327
-235,878
| -47% | -$13.4M |
|
623
Rapid7
RPD
$799M
| $14M | 0.03% |
323,248
+158,478
| +96% | +$8.31M |
|
624
lululemon athletica
LULU
$13.7B
| $14M | 0.03% |
73,712
-95,400
| -56% | -$21.3M |
|
625
Sinclair Inc
SBGI
$1.04B
| $14M | 0.03% |
867,614
+344,992
| +66% | +$8.97M |
|
Similar funds
Israel Englander's Q1 2020 Portfolio in Review
As of Q1 2020, Israel Englander held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Danaher worth $133M.
- Israel Englander's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Israel Englander added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Israel Englander's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Israel Englander fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Israel Englander opened 789 new positions and closed 1,154 in Q1 2020.
- Israel Englander's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.